When Santa Brings Joy at Christmas, Injiva Bring Infections and Unintended Pregnancies: The Hidden HIV Threat Facing Mat South Girls

By Michael Gwarisa in Mat South In most parts of Matabeleland South, the festive season does not only bring tinsel and holiday cheer. It brings something far more complicated. Bottle store owners and shopkeepers prepare for football tournaments that turn their businesses into instant profit zones, while a quieter and more vulnerable anticipation grows among young girls in the villages. They know the Injiva are coming. These are men returning from South Africa or Botswana with cash in hand and the confidence to spend it. For many girls, the homecoming…

Read More

An HIV Wave Hitting Only One Side of the Market: Women in Mat South Are Bearing the Brunt

By Michael Gwarisa in Mat South In Matabeleland South, the burden of new HIV infections falls almost exclusively on women. The numbers are more than statistics; they depict a crisis where mothers and daughters are diagnosed one after the other, while men’s rates lag behind. This imbalance is shrinking families, disrupting livelihoods, and leaving communities to pick up the pieces. Data from the 2022 National Housing and Population Census shows that Matabeleland South has an estimated population of 760,000 people. Of these, the National AIDS Council (NAC) estimates that 93,000…

Read More

Zimbabwe’s Medicines Regulatory Body Registers Lencapavir

By Michael Gwarisa The Medicines Control Authority of Zimbabwe (MCAZ) has announced the expedited approval of Lenacapavir, an innovative long-acting medicine for pre exposure prophylaxis (PrEP) to prevent HIV-1 infection. The MCAZ Director-General, Mr. Richard T. Rukwata, said “the rapid approval of Lenacapavir reflects the Authority’s dedication to accelerating access to trusted, high-quality health products and brings new hope for HIV prevention while reinforcing its commitment to safeguarding public health.” Lenacapavir was assessed and approved by the Registration Committee under the expedited review process, as it is considered to be…

Read More

Funding Cuts Push Zimbabwe to Consider Reusable Circumcision Kits

By Michael Gwarisa Zimbabwe is exploring the use of reusable circumcision kits to sustain voluntary medical male circumcision (VMMC) services amid declining international funding and the gradual withdrawal of donor support. VMMC has been a key HIV prevention tool in Zimbabwe, credited with significantly reducing new HIV infections since the program’s launch in 2009. At its peak in 2012, the program recorded over 1.1 million circumcisions, contributing to the national goal of achieving 80% coverage among adult males and newborns. In the long term, Zimbabwe aimed to maintain around 150,000…

Read More

Zimbabwe to Prioritise Local Funding in New HIV Strategy

By Michael Gwarisa Zimbabwe is set to begin developing its fifth Zimbabwe National HIV and AIDS Strategic Plan (ZNASP V), which will guide the country’s HIV response from 2026 to 2030. The forthcoming strategy follows the successful implementation of ZNASP IV, which runs until 2025 and has seen major progress in the fight against HIV. Under ZNASP IV, Zimbabwe achieved remarkable milestones, including meeting the global 95-95-95 targets — where 95% of people living with HIV know their status, 95% of those diagnosed are on treatment, and 95% of those…

Read More

United Nations Proposes Shutting Down UNAIDS In 2026

By Staff Reporter  The United Nations (UN) agency focusing on the HIV/AIDS pandemic could close by the end of next year as the UN restructures in the face of a funding crisis, according to a UN document published online. UNAIDS will “sunset” by the end of 2026, the document published on Thursday reads, part of a set of proposals from the UN to member states which they will have to decide on. It adds that UNAIDS’ expertise should be shifted into the wider UN system in the following year. The…

Read More

Zimbabwe Selected Among Ten Countries to Roll Out Breakthrough HIV Prevention Drug, Lenacapavir

By Michael Gwarisa  Zimbabwe has been selected as one of ten countries globally to roll out lenacapavir, a revolutionary new HIV prevention drug that is being hailed as a game-changer in the global fight against HIV. The announcement was made on the official U.S. Embassy Zimbabwe Facebook page, marking a historic milestone in the country’s decades-long battle to curb new HIV infections. Lenacapavir, developed by U.S.-based Gilead Sciences in partnership with the Global Fund, is the world’s first twice-yearly HIV prevention medicine. Clinical trial data shows that more than 99%…

Read More

Dust, Gold, and Infection: Midlands Province Grapples with Mining-Driven HIV Epidemic

A young artisanal miner operates a lever at a mine shaft in Gokwe, Zimbabwe, highlighting the risks faced by children working in unsafe mining environments.

By Michael Gwarisa in Midlands Province As one descends the winding Boterekwa curves in Shurugwi in the Midlands province, the scale of mining activity becomes impossible to ignore. The landscape has transformed dramatically since the turn of the millennium. In the distance, rocks are blasted from the earth, sending thick clouds of dust into the sky. Just past the curves, Musasa Shopping Centre is a hive of activity. Evidence of the night’s revelry litters the open space, with empty beer bottles and used condoms scattered near Chirasha Bar, one of…

Read More

UNAIDS Welcomes US Move to Expand HIV Prevention Access

By Staff Reporter  UNAIDS welcomes the announcement by the US State Department that the President’s Emergency Plan for AIDS Relief (PEPFAR) will be supporting an initiative by the Global Fund to Fight AIDS, TB and Malaria to provide lenacapavir to up to 2 million people in countries with high burdens of HIV. Lenacapavir, an American-based innovation, is one of the most promising new HIV prevention tools that has emerged in the HIV response, offering protection against HIV with just twice-yearly injections. The breakthrough medicine will save thousands of lives if…

Read More

Donor Funding Cuts Deal Major Blow To Male Circumcision Programs In Midlands Province

Dr. Mary Muchekeza, Provincial Medical Director for Midlands, addressing journalists in Gweru on the impact of donor funding cuts on voluntary medical male circumcision (VMMC) programs.

By Michael Gwarisa in Gweru The Ministry of Health and Child Care (MoHCC) has warned of a decline in the coverage of Voluntary Medical Male Circumcision (VMMC) in the Midlands province owing to major disruptions in donor funding earlier this year. For more than a decade, Zimbabwe’s VMMC program has relied heavily on external financing, particularly from the President’s Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC), as well as grants from the Bill & Melinda Gates Foundation. However, following the freeze…

Read More